CN117156984A - 用于供电子烟吸入的液体组合物 - Google Patents
用于供电子烟吸入的液体组合物 Download PDFInfo
- Publication number
- CN117156984A CN117156984A CN202180095093.9A CN202180095093A CN117156984A CN 117156984 A CN117156984 A CN 117156984A CN 202180095093 A CN202180095093 A CN 202180095093A CN 117156984 A CN117156984 A CN 117156984A
- Authority
- CN
- China
- Prior art keywords
- nicotine
- composition
- cigarettes
- inhalation
- electronic cigarettes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 62
- 239000003571 electronic cigarette Substances 0.000 title claims abstract description 29
- 239000007788 liquid Substances 0.000 title abstract description 12
- 239000000796 flavoring agent Substances 0.000 claims abstract description 8
- 235000013355 food flavoring agent Nutrition 0.000 claims abstract description 6
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 3
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims abstract description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 23
- 241000208125 Nicotiana Species 0.000 claims description 6
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 6
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical group [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 3
- 235000010234 sodium benzoate Nutrition 0.000 claims description 3
- 239000004299 sodium benzoate Substances 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 239000008368 mint flavor Substances 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims description 2
- 229960002715 nicotine Drugs 0.000 abstract description 35
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 abstract description 35
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 abstract description 34
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 9
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 abstract description 5
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 abstract description 5
- 229940035437 1,3-propanediol Drugs 0.000 abstract description 5
- 229920000166 polytrimethylene carbonate Polymers 0.000 abstract description 5
- 235000019504 cigarettes Nutrition 0.000 description 14
- 238000012360 testing method Methods 0.000 description 13
- 239000002245 particle Substances 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 11
- 229960004063 propylene glycol Drugs 0.000 description 7
- 230000000391 smoking effect Effects 0.000 description 7
- 239000000443 aerosol Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 238000002485 combustion reaction Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 229910002091 carbon monoxide Inorganic materials 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 2
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 239000000779 smoke Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000001246 colloidal dispersion Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000005595 deprotonation Effects 0.000 description 1
- 238000010537 deprotonation reaction Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000004005 nitrosamines Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000021317 sensory perception Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
- A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
- A24B15/241—Extraction of specific substances
- A24B15/243—Nicotine
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/301—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by aromatic compounds
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/32—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by acyclic compounds
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
- A24B15/40—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms
- A24B15/403—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacture Of Tobacco Products (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102021000005027A IT202100005027A1 (it) | 2021-03-04 | 2021-03-04 | Composizione liquida da inalazione per sigarette elettroniche |
IT102021000005027 | 2021-03-04 | ||
PCT/IB2021/062189 WO2022185117A1 (en) | 2021-03-04 | 2021-12-22 | Liquid composition for inhalation for electronic cigarettes |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117156984A true CN117156984A (zh) | 2023-12-01 |
Family
ID=75850578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202180095093.9A Pending CN117156984A (zh) | 2021-03-04 | 2021-12-22 | 用于供电子烟吸入的液体组合物 |
Country Status (10)
Country | Link |
---|---|
US (1) | US20240148046A1 (ko) |
EP (1) | EP4301165A1 (ko) |
JP (1) | JP2024508528A (ko) |
KR (1) | KR20230154446A (ko) |
CN (1) | CN117156984A (ko) |
AU (1) | AU2021431664A1 (ko) |
CA (1) | CA3211812A1 (ko) |
IT (1) | IT202100005027A1 (ko) |
WO (1) | WO2022185117A1 (ko) |
ZA (1) | ZA202308964B (ko) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201817859D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolisable formulation |
EP3979841B1 (en) * | 2019-06-05 | 2023-04-19 | Philip Morris Products S.A. | Nicotine composition, method for making and aerosol generating articles comprising such |
EP3979820B1 (en) * | 2019-06-05 | 2023-08-02 | Philip Morris Products S.A. | Liquid tobacco extract, method for making and aerosol-generating articles comprising such |
-
2021
- 2021-03-04 IT IT102021000005027A patent/IT202100005027A1/it unknown
- 2021-12-22 US US18/548,533 patent/US20240148046A1/en active Pending
- 2021-12-22 CA CA3211812A patent/CA3211812A1/en active Pending
- 2021-12-22 WO PCT/IB2021/062189 patent/WO2022185117A1/en active Application Filing
- 2021-12-22 EP EP21830520.9A patent/EP4301165A1/en active Pending
- 2021-12-22 KR KR1020237033352A patent/KR20230154446A/ko unknown
- 2021-12-22 AU AU2021431664A patent/AU2021431664A1/en active Pending
- 2021-12-22 CN CN202180095093.9A patent/CN117156984A/zh active Pending
- 2021-12-22 JP JP2023553487A patent/JP2024508528A/ja active Pending
-
2023
- 2023-09-21 ZA ZA2023/08964A patent/ZA202308964B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2021431664A1 (en) | 2023-09-14 |
US20240148046A1 (en) | 2024-05-09 |
EP4301165A1 (en) | 2024-01-10 |
ZA202308964B (en) | 2024-05-30 |
CA3211812A1 (en) | 2022-09-09 |
WO2022185117A1 (en) | 2022-09-09 |
IT202100005027A1 (it) | 2022-09-04 |
JP2024508528A (ja) | 2024-02-27 |
KR20230154446A (ko) | 2023-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2831124T3 (es) | Solución que comprende nicotina en forma no protonada y en forma protonada | |
EP2790536B1 (en) | Device and method for simulating chemosensation of smoking | |
US9854836B2 (en) | Aerosol generator | |
KR101208473B1 (ko) | 전자 담배용 무화용액 조성물 | |
EP1458252A2 (en) | Tobacco and/or tobacco substitute composition for use as a snuff in the oral cavity | |
KR20100028182A (ko) | 전자 담배용 니코틴 수용액 | |
KR20210075107A (ko) | 에어로졸화 가능한 포뮬레이션 | |
JP2021534812A (ja) | 組成物 | |
KR20210069681A (ko) | 에어로졸화 가능한 포뮬레이션 | |
KR101257828B1 (ko) | 다마스콘 함유 금연보조제 조성물 | |
RU2745353C1 (ru) | Ароматизированная испаряемая композиция | |
US20050263165A1 (en) | Tobacco leaf substitute | |
CN117156984A (zh) | 用于供电子烟吸入的液体组合物 | |
US20040094170A1 (en) | Nicotine free cigarette substitute | |
JP2024504989A (ja) | エアロゾル生成材料及びその使用 | |
KR20210150547A (ko) | 소모품 | |
CN111227295A (zh) | 一种无烟型电子雾化液及制备方法 | |
US20220022521A1 (en) | New tobacco substitutes | |
EP4138585B1 (en) | Aerosolisable formulation | |
RU2788010C2 (ru) | Способная образовывать аэрозоль композиция | |
RU2800011C2 (ru) | Способная образовывать аэрозоль композиция | |
TW202423309A (zh) | 消耗品 | |
CA2123853C (en) | Smoking suppressant and method of application thereof | |
WO2023008063A1 (ja) | 電子タバコ用リキッド、および電子タバコ用リキッドの製造方法、ならびに電子タバコ用カートリッジ、電子タバコ | |
AU2022433868A1 (en) | Aerosolisable material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |